Edward M. Kaye

2022 - Stoke Therapeutics

In 2022, Edward M. Kaye earned a total compensation of $5.7M as Chief Executive Officer at Stoke Therapeutics, a 33% decrease compared to previous year.

Compensation breakdown

Bonus$32,293
Non-Equity Incentive Plan$290,636
Option Awards$4,817,310
Salary$596,083
Other$12,200
Total$5,748,522

Kaye received $4.8M in option awards, accounting for 84% of the total pay in 2022.

Kaye also received $32.3K in bonus, $290.6K in non-equity incentive plan, $596.1K in salary and $12.2K in other compensation.

Rankings

In 2022, Edward M. Kaye's compensation ranked 536th out of 5,753 executives tracked by ExecPay. In other words, Kaye earned more than 90.7% of executives.

ClassificationRankingPercentile
All
536
out of 5,753
91st
Division
Manufacturing
227
out of 3,133
93rd
Major group
Chemicals And Allied Products
70
out of 1,419
95th
Industry group
Drugs
58
out of 1,320
96th
Industry
Pharmaceutical Preparations
42
out of 966
96th
Source: SEC filing on September 28, 2023.

Kaye's colleagues

We found two more compensation records of executives who worked with Edward M. Kaye at Stoke Therapeutics in 2022.

2022

Barry Ticho

Stoke Therapeutics

Chief Medical Officer

2022

Stephen Tulipano

Stoke Therapeutics

Chief Financial Officer

News

In-depth

You may also like